You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 9, September 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Invited Critique
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Patient-Physician Communication
 •End-of-life Care/ Palliative Medicine
 •Congenital Malformations
 •Neonatology and Infant Care
 •Cardiovascular System
 •Surgery
 •Pediatric Surgery
 •Prognosis/ Outcomes
 •Congenital Heart Defects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ethics in the Midst of Therapeutic Evolution

Chris Feudtner, MD, PhD, MPH

Arch Pediatr Adolesc Med. 2008;162(9):854-857.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

What ethical challenges arise when, in an era like ours, the frequent arrival of new therapeutic interventions constantly transforms the status quo of health care, pushing forward the boundary of what is possible and, perhaps, desirable? Several of these challenges come into particular focus in 2 articles in this issue of Archives. Both articles scrutinize the treatment options offered to parents of infants with hypoplastic left heart syndrome (HLHS), and both reach resolute but differing opinions regarding whether palliative care should be routinely offered.While this debate involves data that are very specific to HLHS, data that have changed over time and likely vary across treatment centers, close examination of the arguments reveals more general issues about how complex clinical treatment decisions are—and should be—made.

INFORMED CONSENT AND CLINICIAN INTEGRITY

Two core concepts provide the foundation for our inquiry: informed consent and clinician integrity. Of these two, the doctrine of . . . [Full Text of this Article]


THE TASKS OF COMPLEX THERAPEUTIC DECISION MAKING

BALANCE IN THE ETHICS OF MEDICAL DECISION MAKING

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Healthcare Providers Must Offer Palliative Treatment to Parents of Neonates With Hypoplastic Left Heart Syndrome
Alexander A. Kon
Arch Pediatr Adolesc Med. 2008;162(9):844-848.
EXTRACT | FULL TEXT  

The Paradigm Shift Toward Surgical Intervention for Neonates With Hypoplastic Left Heart Syndrome
Gil Wernovsky
Arch Pediatr Adolesc Med. 2008;162(9):849-854.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.